HEPATITIS B VIRUS - CHRONIC ACTIVE

Clinical trials for HEPATITIS B VIRUS - CHRONIC ACTIVE explained in plain language.

Never miss a new study

Get alerted when new HEPATITIS B VIRUS - CHRONIC ACTIVE trials appear

Sign up with your email to follow new studies for HEPATITIS B VIRUS - CHRONIC ACTIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Could a short course of antiviral drugs stop hepatitis b passing from mother to child?

Disease control Recruiting now

This trial tests whether giving the antiviral drug tenofovir disoproxil fumarate (TDF) to pregnant women with active hepatitis B can prevent the virus from spreading to their babies. The women take TDF from the 28th week of pregnancy until six weeks after giving birth, and all ne…

Matched conditions: HEPATITIS B VIRUS - CHRONIC ACTIVE

Phase: PHASE4 • Sponsor: ANRS, Emerging Infectious Diseases • Aim: Disease control

Last updated Jul 01, 2026 00:00 UTC

HEPATITIS B VIRUS - CHRONIC ACTIVE

Get alerted when new HEPATITIS B VIRUS - CHRONIC ACTIVE trials appear

Could a short course of antiviral drugs stop hepatitis b passing from mother to child?